Behar J, Corazziari E, Guelrud M, Hogan W, Sherman S, Toouli J. Functional gallbladder and sphincter of oddi disorders. Gastroenterology. 2006;130:1498–509.

Article  PubMed  Google Scholar 

Hogan WJ, Geenen JE. Biliary dyskinesia. Endoscopy. 1988;20:179–83.

Article  PubMed  Google Scholar 

Geenen JE, Hogan WJ, Dodds WJ, Toouli J, Venu RP. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-Oddi dysfunction. N Engl J Med. 1989;320:82–7.

Article  CAS  PubMed  Google Scholar 

Cotton PB, Elta GH, Carter CR, Pasricha PJ, Corazziari ES, Rome IV. Gallbladder and sphincter of Oddi disorders. Gastroenterology. 2016;150:1420–9.

Article  Google Scholar 

Baillie J. Sphincter of Oddi dysfunction: overdue for an overhaul. Am J Gastroenterol. 2005;100:1217–20.

Article  PubMed  Google Scholar 

Menon S, Holt A, Farmer AD. Intra-sphincteric botulinum toxin in the management of functional biliary pain. Endosc Int Open. 2022;10:E521–7.

Article  PubMed  PubMed Central  Google Scholar 

Cotton PB, Durkalski V, Romagnuolo J, et al. Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy: the EPISOD randomized clinical trial. JAMA. 2014;311:2101–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Menon S, Kurien R, Mathew R. The role of intrasphincteric botulinum toxin injection in the management of functional biliary pain: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2020;32:984–9.

Article  PubMed  Google Scholar 

Singh JA. Use of botulinum toxin in musculoskeletal pain. F1000Res. 2013;2:52.

Article  PubMed  PubMed Central  Google Scholar 

Colhado OC, Boeing M, Ortega LB. Botulinum toxin in pain treatment. Rev Bras Anestesiol. 2009;59:366–81.

Article  CAS  PubMed  Google Scholar 

Wheeler AH, Goolkasian P. Open label assessment of botulinum toxin A for pain treatment in a private outpatient setting. J Musculoskelet Pain. 2001;9:67–82.

Article  Google Scholar 

ASGE Standards of Practice Committee, Chandrasekhara V, Khashab MA, et al. Adverse events associated with ERCP. Gastrointest Endosc. 2017;85:32–47.

Article  Google Scholar 

British Pain Society. Outcome measures. Churchill House, 35 Red Lion Square, London WC1R 4SG: The Faculty of Pain Medicine of the Royal College of Anaesthetists, 2019. https://www.britishpainsociety.org/static/uploads/resources/files/Outcome_Measures_January_2019.pdf

Pasricha PJ, Sostre S, Kalloo AN. Endoscopic injection of botulinum toxin for patients with suspected sphincter of Oddi dysfunction: results of a pilot trial. Gastrointest Endosc. 1994;40:421.

Google Scholar 

Pasricha PJ. Unraveling the mystery of pain in chronic pancreatitis. Nat Rev Gastroenterol Hepatol. 2012;9:140–51.

Article  CAS  PubMed  Google Scholar 

Li C, Zhu Y, Shenoy M, Pai R, Liu L, Pasricha PJ. Anatomical and functional characterization of a duodeno-pancreatic neural reflex that can induce acute pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2013;304:G490-500.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karthik A, Subramanian G, Mallikarjuna Rao C, et al. Simultaneous determination of pioglitazone and glimepiride in bulk drug and pharmaceutical dosage form by RP-HPLC method. Pak J Pharm Sci. 2008;21:421–5.

CAS  Google Scholar 

Desautels SG, Slivka A, Hutson WR, et al. Postcholecystectomy pain syndrome: pathophysiology of abdominal pain in sphincter of Oddi type III. Gastroenterology. 1999;116:900–5.

Article  CAS  PubMed  Google Scholar 

Pasricha PJ, Miskovsky EP, Kalloo AN. Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction. Gut. 1994;35:1319–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Austin AS, Wheeler K, Larvin M, et al. Transient response to botulinum toxin injection predicts the medium-term outcome after endoscopic sphincterotomy in type 2/3 sphincter of Oddi dysfunction. Gut. 2010;59:PTU-001.

Article  Google Scholar 

Wehrmann T, Seifert H, Seipp M, et al. Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction. Endoscopy. 1998;30:702–7.

Article  CAS  PubMed  Google Scholar 

Wheeler K, Salmon CA, Austin AS. Response to peri-ampullary botox injection and subsequent long term response to endoscopic sphincterotomy in type 2/3 sphincter of Oddi dysfunction. Gut. 2014;63:PTH-012.

Article  Google Scholar 

Musial F, Klosterhalfen S, Enck P. Placebo responses in patients with gastrointestinal disorders. World J Gastroenterol. 2007;13:3425–9.

Article  PubMed  PubMed Central  Google Scholar 

Enck P, Klosterhalfen S. The placebo response in functional bowel disorders: perspectives and putative mechanisms. Neurogastroenterol Motil. 2005;17:325–31.

Article  CAS  PubMed  Google Scholar 

Lacy BE, Weiser K, Kennedy A. Botulinum toxin and gastrointestinal tract disorders: panacea, placebo, or pathway to the future? Gastroenterol Hepatol (N Y). 2008;4:283–95.

PubMed  Google Scholar 

Richardson WS, Willis GW, Smith JW. Evaluation of scar formation after botulinum toxin injection or forced balloon dilation to the lower esophageal sphincter. Surg Endosc. 2003;17:696–8.

Article  CAS  PubMed  Google Scholar 

Cowgill SM, Villadolid DV, Al-Saadi S, Rosemurgy AS. Difficult myotomy is not determined by preoperative therapy and does not impact outcome. JSLS. 2007;11:336–43.

PubMed  PubMed Central  Google Scholar 

Bloomston M, Fraiji E, Boyce HW Jr, et al. Preoperative intervention does not affect esophageal muscle histology or patient outcomes in patients undergoing laparoscopic Heller myotomy. J Gastrointest Surg. 2003;7:181–8.

Article  PubMed  Google Scholar 

Shearman R. Abdominal pain. In: Walker H, Hall W, Hurst J, editors. Clinical Methods. 3rd ed. The History, Physical, and Laboratory Examinations: Butterworths; 1990.

Roberts KJ, Ismail A, Coldham C, Buckels J, Bramhall S. Long-term symptomatic relief following surgical sphincteroplasty for sphincter of Oddi dysfunction. Dig Surg. 2011;28:304–8.

Article  CAS  PubMed  Google Scholar